The patch can watch every heartbeat for adverse cardiac events and transmit findings, in near real-time, to a clinical service center for immediate follow-up.
The new CEO, Vic Gundotra, served as Senior Vice President at Google from 2011 until April 2014, heading up the company's social initiatives.
The new offering uses the same technology as smartphone-based AliveECG, relying on a single-lead sensor built into a replacement watchband.
The new feature enables AliveCor users to add events and tags around their ECG recordings, such as drinking coffee, to better understand their heart health.
The feature provides added peace of mind allowing patients to go about their regular daily activities knowing that no abnormalities were detected in their ECG.
The application crashing issues affected some 5,600 iOS users, according to a FDA recall notice; an updated version of the app has been promptly release.
The user's heart rate is recorded from AliveCor's Heart Monitor; and for those without an ECG reader - heart rates can be input manually or from another sensor.
The Normal Detector identifies when no abnormalities are detected in an ECG, while the Interference Detector identifies if factors have affected the recording.
The study found that the AliveCor Heart Monitor had 100% sensitivity, and 97% specificity for detecting atrial fibrillation (AF) and atrial flutter, combined.
The new device is not only thinner and lighter than its predecessor -- but at $74.99, also more affordable; it was designed in collaboration with IDEO.